OKYO Pharma Limited ("OKYO" or the "Company") - Company Presentation

LONDON, Aug. 03, 2020 (GLOBE NEWSWIRE) -- OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that, further to the announcement made on Friday 31 July, the investor webinar, hosted by RedChip Companies, on Sunday, August 2, 2020 can be viewed at https://youtu.be/l8onUtOvSqQ.

About OKYO

OKYO Pharma Limited (LSE: OKYO) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange plc. OKYO is focusing on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain.

Enquiries:

For further information, please visit the Company's website at www.okyopharma.com.